Mark Throdahl
Presidente presso ORTHOPEDIATRICS CORP.
Patrimonio netto: 5 M $ in data 31/05/2024
Posizioni attive di Mark Throdahl
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ORTHOPEDIATRICS CORP. | Presidente | 03/06/2021 | - |
| Direttore/Membro del Consiglio | 01/01/2009 | 03/06/2021 | |
| Amministratore Delegato | 01/01/2011 | 03/06/2021 | |
| Presidente | 01/01/2011 | 03/06/2020 |
Storia della carriera di Mark Throdahl
Precedenti posizioni note di Mark Throdahl
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. | Corporate Officer/Principal | 01/05/2008 | 12/06/2009 |
| CONSORT MEDICAL PLC | Amministratore Delegato | 01/06/2001 | 05/12/2007 |
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | 01/06/1988 | 01/06/2001 |
Nippon Becton Dickinson Co. Ltd.
 Nippon Becton Dickinson Co. Ltd. Medical SpecialtiesHealth Technology Part of Becton, Dickinson & Co., Nippon Becton Dickinson Co. Ltd. is a Japanese company that specializes in providing high-quality products and services for infections and diagnosis of infectious diseases. The company is based in Tokyo, Japan. The company has contributed to speeding up tests and improving test accuracy as a world-leading company. AMR (drug resistance) is a major concern for everyone, regardless of age or country, and the company has been at the forefront of combating this issue. | Presidente | 01/01/1988 | 01/01/2001 |
Mallinckrodt, Inc.(Old)
 Mallinckrodt, Inc.(Old) Medical SpecialtiesHealth Technology Mallinckrodt, Inc. developed manufactured and marketed medical products for hospitals. It provided specialty healthcare products for diagnostic imaging, respiratory care and pain relief. The firm sold its products to hospitals, alternate care sites, drug manufacturers and clinical laboratories. The company was founded in 1867 and was headquartered in Hazelwood, MO. | Corporate Officer/Principal | 01/01/1975 | 01/06/1983 |
Formazione di Mark Throdahl
| Princeton University | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Regno Unito | 2 |
| Giappone | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 2 |
| President | 2 |
Settori
| Health Technology | 7 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| ZIMMER BIOMET HOLDINGS, INC. | Health Technology |
| ORTHOPEDIATRICS CORP. | Health Technology |
| Aziende private | 3 |
|---|---|
Mallinckrodt, Inc.(Old)
Mallinckrodt, Inc.(Old) Medical SpecialtiesHealth Technology Mallinckrodt, Inc. developed manufactured and marketed medical products for hospitals. It provided specialty healthcare products for diagnostic imaging, respiratory care and pain relief. The firm sold its products to hospitals, alternate care sites, drug manufacturers and clinical laboratories. The company was founded in 1867 and was headquartered in Hazelwood, MO. | Health Technology |
Consort Medical Ltd.
 Consort Medical Ltd. Pharmaceuticals: MajorHealth Technology Consort Medical Ltd. is a holding company, which engages in pharmaceutical industry related activities. It focuses on the design, development, manufacture, and sale of medical drug and delivery devices. The company was founded on March 22, 1946 and is headquartered in Kings Lynn, the United Kingdom. | Health Technology |
Nippon Becton Dickinson Co. Ltd.
Nippon Becton Dickinson Co. Ltd. Medical SpecialtiesHealth Technology Part of Becton, Dickinson & Co., Nippon Becton Dickinson Co. Ltd. is a Japanese company that specializes in providing high-quality products and services for infections and diagnosis of infectious diseases. The company is based in Tokyo, Japan. The company has contributed to speeding up tests and improving test accuracy as a world-leading company. AMR (drug resistance) is a major concern for everyone, regardless of age or country, and the company has been at the forefront of combating this issue. | Health Technology |
- Borsa valori
- Insiders
- Mark Throdahl
- Esperienza
